Table 2.

Change in weight, BP, and glucose levels from baseline to week 52 in patients in the highest and lowest cumulative corticosteroid dose quartiles^a

	Highest quartile of cumulative corticosteroid dose		Lowest quartile of cumulative corticosteroid dose		Highest quartile of cumulative oral corticosteroid dose		Lowest quartile of cumulative oral corticosteroid dose
	Belimumab 10 mg/kg (n = 79)	Placebo (n = 80)	Belimumab 10 mg/kg (n = 112)	Placebo (n = 99)	Belimumab 10 mg/kg (n = 99)	Placebo (n = 90)	Belimumab 10 mg/kg (n = 112)	Placebo (n = 97)
Weight, kg	2.5 ± 4.66	2.5 ± 6.71b	0.8 ± 4.08	−0.1 ± 3.56	2.5 ± 4.50	2.3 ± 6.26b	0.7 ± 4.19	0.0 ± 3.42
Systolic BP, mm Hg	−2.2 ± 17.62	−2.8 ± 17.20	−3.2 ± 15.96	−3.6 ± 14.10	−2.9 ± 16.89	−2.3 ± 16.52	−3.4 ± 16.01b	−3.3 ± 14.62
Diastolic BP, mm Hg	−2.5 ± 11.52	−2.5 ± 12.77	−1.5 ± 10.60	−1.9 ± 10.38	−2.2 ± 10.77	−2.4 ± 12.31	−1.3 ± 10.80b	−1.6 ± 10.45
Glucose, mmoles/liter	0.3 ± 1.90	0.1 ± 1.44b	0.2 ± 1.46	0.0 ± 1.41b	0.2 ± 1.79	0.1 ± 1.34b	0.1 ± 1.45	0.0 ± 1.42b

^aValues are the mean ± SD. BP = blood pressure.

^bData were missing for 1 patient.